How do you approach management of locally-advanced, unresectable, but non-metastatic bladder cancer?
When do you offer trimodality bladder-sparing approaches? Is there any role for starting standard neoadjuvant therapy in an attempt to convert to resectable disease?
1 Answer
Mednet MemberInvited Expert
Medical Oncology · University of Utah Huntsman Cancer Institute
Answered on
"Locally advanced" has a broad meaning. I will focus on muscle invasive urothelial carcinoma which is non-metastatic, node negative, and does not invade the pelvic or abdominal wall, and is a maximum of T4a, N0, M0 disease, and in those patients who either have unresectable disease or who are not su...
Join for free or sign in to see the full answer